Wordt geladen...
CREB Signals as PBMC-based Biomarkers of Cognitive Dysfunction: A Novel Perspective of the Brain-Immune Axis
To date, there is no reliable biomarker for the assessment or determination of cognitive dysfunction in Alzheimer’s disease and related dementia. Such a biomarker would not only aid in diagnostics, but could also serve as a measure of therapeutic efficacy. It is widely acknowledged that the hallmark...
Bewaard in:
| Gepubliceerd in: | Brain Behav Immun |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6488430/ https://ncbi.nlm.nih.gov/pubmed/30641141 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbi.2019.01.004 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|